155 related articles for article (PubMed ID: 37559945)
1. Prevalence of HIV-1 infection and associated characteristics in a Brazilian indigenous population: a cross-sectional study.
Schnaufer ECS; Barbosa MS; Marques MFR; Brito GT; Ferreira TS; Ribeiro ADC; Valiente AC; Machado IR; Gonçalves CCM; Tanaka TSO; Guimarães ML; Ribeiro SM; Croda J; Simionatto S
Lancet Reg Health Am; 2023 Sep; 25():100562. PubMed ID: 37559945
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. HTLV infection in Brazil's second-largest indigenous reserve.
Amianti C; Bandeira LM; Cesar GA; Weis-Torres S; Tanaka TSO; Machado IR; Gonçalves CCM; Simionatto S; Schnaufer ECDS; Freitas FB; Vallinoto ACR; Croda J; Motta-Castro ARC
Sci Rep; 2022 Oct; 12(1):16701. PubMed ID: 36202887
[TBL] [Abstract][Full Text] [Related]
4. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological aspects of HIV infection and AIDS among indigenous populations.
Graeff SV; Pícolli RP; Arantes R; Castro VOL; Cunha RVD
Rev Saude Publica; 2019 Sep; 53():71. PubMed ID: 31508778
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: a population-based linkage study.
Nery JS; Ramond A; Pescarini JM; Alves A; Strina A; Ichihara MY; Fernandes Penna ML; Smeeth L; Rodrigues LC; Barreto ML; Brickley EB; Penna GO
Lancet Glob Health; 2019 Sep; 7(9):e1226-e1236. PubMed ID: 31331811
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological Survey of Human Alphaherpesvirus 2 (HSV-2) Infection in Indigenous People of Dourados Municipality, Central Brazil.
Bonfim FFO; Villar LM; Croda J; Silva SRD; Gonçalves CCM; de Castro VOL; de Rezende Romeira GR; Cesar GA; Dos Santos Weis-Torres SM; Horta MA; Simionatto S; Motta-Castro ARC; de Paula VS
Trop Med Infect Dis; 2023 Mar; 8(4):. PubMed ID: 37104324
[TBL] [Abstract][Full Text] [Related]
8. Recent changes in growth trajectories: a population-based cohort study of over 5 million Brazilian children born between 2001 and 2014.
Santiago-Vieira C; Velasquez-Melendez G; de Cássia Ribeiro-Silva R; de Jesus Pinto E; Barreto ML; Li L
Lancet Reg Health Am; 2024 Apr; 32():100721. PubMed ID: 38629028
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Netto LC; Ibrahim KY; Picone CM; Alves APPS; Aniceto EV; Santiago MR; Parmejani PSS; Aikawa NE; Medeiros-Ribeiro AC; Pasoto SG; Yuki EFN; Saad CGS; Pedrosa T; Lara AN; Ceneviva C; Bonfa E; Kallas EG; Avelino-Silva VI
Lancet HIV; 2022 May; 9(5):e323-e331. PubMed ID: 35338835
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy.
Gomes I; Karmirian K; Oliveira JT; Pedrosa CDSG; Mendes MA; Rosman FC; Chimelli L; Rehen S
Lancet Reg Health Am; 2021 Oct; 2():100046. PubMed ID: 34485969
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence Of SARS-COV-2 infection in asymptomatic indigenous from the largest Brazilian periurban area.
de Oliveira LA; Dos Santos Barbosa M; Leite Torres AJ; Croda MG; Oliveira da Silva B; Dos Santos PCP; Rossoni R; Machado LOCL; Croda J; Maymone Gonçalves CC; Marques MF; da Silva Ferreira T; Sardi SI; Campos GS; de Almeida GB; Alves Gomes MM; Marchioro SB; Simionatto S
PLoS One; 2023; 18(12):e0295211. PubMed ID: 38134187
[TBL] [Abstract][Full Text] [Related]
13. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil.
de Almeida Pereira RA; Mussi AD; de Azevedo e Silva VC; Souto FJ
BMC Infect Dis; 2006 Feb; 6():34. PubMed ID: 16504137
[TBL] [Abstract][Full Text] [Related]
16. Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX - REVOLUTIOn trial.
Maia IS; Marcadenti A; Veiga VC; Miranda TA; Gomes SPC; Carollo MBS; Negrelli KL; Gomes JO; Tramujas L; Abreu-Silva EO; Westphal GA; Fernandes RP; Horta JGA; Oliveira DC; Flato UAP; Paoliello RCR; Fernandes C; Zandonai CL; Coelho JC; Barros WC; Lemos JC; Bolan RS; Dutra MM; Gebara OCE; Lopes ATA; Alencar Filho MS; Arraes JA; Hamamoto VA; Hernandes ME; Golin NA; Santos TM; Santos RHN; Damiani LP; Zampieri FG; Gesto J; Machado FR; Rosa RG; Azevedo LCP; Avezum A; Lopes RD; Souza TML; Berwanger O; Cavalcanti AB;
Lancet Reg Health Am; 2023 Apr; 20():100466. PubMed ID: 36908503
[TBL] [Abstract][Full Text] [Related]
17. Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis.
Ferreira LS; Darcie Marquitti FM; Paixão da Silva RL; Borges ME; Ferreira da Costa Gomes M; Cruz OG; Kraenkel RA; Coutinho RM; Prado PI; Bastos LS
Lancet Reg Health Am; 2023 Jan; 17():100397. PubMed ID: 36439909
[TBL] [Abstract][Full Text] [Related]
18. Suicide trends and characteristics among persons in the Guaraní Kaiowá and Nandeva communities--Mato Grosso do Sul, Brazil, 2000-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jan; 56(1):7-9. PubMed ID: 17218936
[TBL] [Abstract][Full Text] [Related]
19. [Financing of the scientific publication and protection of the scientific knowledge].
Oliveira Filho RS; Hochman B; Nahas FX; Ferreira LM
Acta Cir Bras; 2005; 20 Suppl 2():35-9. PubMed ID: 16283026
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Treponema pallidum infection in Brazilian indigenous people: a cross-sectional study.
Barbosa MS; Queiroz JHFS; Schnaufer ECS; Silva GD; Marques MFR; Ferreira TS; de Souza GHA; Gonçalves CCM; Marchioro SB; Simionatto S
Sci Rep; 2024 May; 14(1):11822. PubMed ID: 38782949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
